This leads to an increased production of reactive oxygen species (ROS), resulting in cellular damage, heightened inflammation, and impaired immunity
The post pairs that with frequent check-ins with gastroenterology and a predefined plan to stop treatment if the colitis worsens, emphasizing open communication among all the treating clinicians involved
and Demonstrate a substantial clinical improvement, that is, substantially improve the diagnosis or treatment of an illness or injury or improve the functioning of a malformed body part compared to the benefits of a device or devices in a previously established category or other available treatment, or, for devices for which pass-through payment status will begin on or after January 1, 2020, as an alternative pathway to demonstrating substantial clinical improvement, a device is part of the FDA's Breakthrough Devices Program and has received marketing authorization for the indication covered by the Breakthrough Device designation
According to the FDA's approval, the eligibility criteria are as follows: For Adults: A Body Mass Index (BMI) of 30 kg/m or greater (defined as obesity), OR a BMI of 27 kg/m or greater (defined as overweight) with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
